Miami, FL12 Active Studies

Interstitial Lung Disease Clinical Trials in Miami, FL

Find 12 actively recruiting interstitial lung disease clinical trials in Miami, FL. Connect with local research sites and explore new treatment options.

12
Active Trials
10
Sponsors
2,692
Enrolling

Recruiting Interstitial Lung Disease Studies in Miami

About Interstitial Lung Disease Clinical Trials in Miami

Interstitial lung disease is a group of disorders characterized by progressive scarring of lung tissue, leading to breathlessness and reduced oxygen exchange. Causes include autoimmune diseases, environmental exposures, and unknown factors. Treatment includes antifibrotic medications and immunosuppressants.

There are currently 12 interstitial lung disease clinical trials recruiting participants in Miami, FL. These studies are seeking a combined 2,692 participants. Research is being sponsored by GAP Innovations, PBC, Trevi Therapeutics, University of Miami and 7 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Interstitial Lung Disease Clinical Trials in Miami — FAQ

Are there interstitial lung disease clinical trials in Miami?

Yes, there are 12 interstitial lung disease clinical trials currently recruiting in Miami, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Miami?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Miami research site will contact you about next steps.

Are clinical trials in Miami free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Miami studies also compensate for your time and travel.

What interstitial lung disease treatments are being tested?

The 12 active trials in Miami are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial lung disease.

Data updated October 15, 2026 from ClinicalTrials.gov